239 related articles for article (PubMed ID: 27874210)
1. Cost effectiveness of using cognitive screening tests for detecting dementia and mild cognitive impairment in primary care.
Tong T; Thokala P; McMillan B; Ghosh R; Brazier J
Int J Geriatr Psychiatry; 2017 Dec; 32(12):1392-1400. PubMed ID: 27874210
[TBL] [Abstract][Full Text] [Related]
2. Screening for Dementia in Primary Care: A Comparison of the GPCOG and the MMSE.
Brodaty H; Connors MH; Loy C; Teixeira-Pinto A; Stocks N; Gunn J; Mate KE; Pond CD
Dement Geriatr Cogn Disord; 2016; 42(5-6):323-330. PubMed ID: 27811463
[TBL] [Abstract][Full Text] [Related]
3. The Efficacy of General Practitioner Assessment of Cognition in Chinese Elders Aged 80 and Older.
Xu F; Ma JJ; Sun F; Lee J; Coon DW; Xiao Q; Huang Y; Zhang L; Liang ZH
Am J Alzheimers Dis Other Demen; 2019; 34(7-8):523-529. PubMed ID: 31266345
[TBL] [Abstract][Full Text] [Related]
4. Cognitive screening tools for primary care settings: examining the 'Test Your Memory' and 'General Practitioner assessment of Cognition' tools in a rural aging population in Greece.
Iatraki E; Simos PG; Bertsias A; Duijker G; Zaganas I; Tziraki C; Vgontzas AN; Lionis C;
Eur J Gen Pract; 2017 Dec; 23(1):171-178. PubMed ID: 28604128
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of the GPCOG, a screening tool for cognitive impairment.
Brodaty H; Kemp NM; Low LF
Int J Geriatr Psychiatry; 2004 Sep; 19(9):870-4. PubMed ID: 15352145
[TBL] [Abstract][Full Text] [Related]
6. The use of the Mini-Cog, MMSE, and GPCOG tests in domestic clinical practice for the evaluation of cognitive disorders in elderly and senile patients: the results of a survey of experts' opinions.
Ionova TI; Frolova EV; Ovakimyan KV; Mkhitaryan EA; Tkacheva ON; Logunov DL; Oskova AY; Vasileva EA; Zhitkova YV; Gasparyan AA; Lunev KV; Luneva EA; Porfirieva NM; Nikitina TP
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(7):55-64. PubMed ID: 37490666
[TBL] [Abstract][Full Text] [Related]
7. The validation of the Italian version of the GPCOG (GPCOG-It): a contribution to cross-national implementation of a screening test for dementia in general practice.
Pirani A; Brodaty H; Martini E; Zaccherini D; Neviani F; Neri M
Int Psychogeriatr; 2010 Feb; 22(1):82-90. PubMed ID: 19891815
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of Memory Assessment Services for the diagnosis and early support of patients with dementia in England.
Gomes M; Pennington M; Wittenberg R; Knapp M; Black N; Smith S
J Health Serv Res Policy; 2017 Oct; 22(4):226-235. PubMed ID: 28622732
[TBL] [Abstract][Full Text] [Related]
9. Who Benefits Most from Collaborative Dementia Care from a Patient and Payer Perspective? A Subgroup Cost-Effectiveness Analysis.
Rädke A; Michalowsky B; Thyrian JR; Eichler T; Xie F; Hoffmann W
J Alzheimers Dis; 2020; 74(2):449-462. PubMed ID: 32039839
[TBL] [Abstract][Full Text] [Related]
10. Six-item cognitive impairment test (6CIT): pragmatic diagnostic accuracy study for dementia and MCI.
Abdel-Aziz K; Larner AJ
Int Psychogeriatr; 2015 Jun; 27(6):991-7. PubMed ID: 25630996
[TBL] [Abstract][Full Text] [Related]
11. The GPCOG: a new screening test for dementia designed for general practice.
Brodaty H; Pond D; Kemp NM; Luscombe G; Harding L; Berman K; Huppert FA
J Am Geriatr Soc; 2002 Mar; 50(3):530-4. PubMed ID: 11943052
[TBL] [Abstract][Full Text] [Related]
12. The 6-Item Cognitive Impairment Test as a bedside screening for dementia in general hospital patients: results of the General Hospital Study (GHoSt).
Hessler JB; Schäufele M; Hendlmeier I; Nora Junge M; Leonhardt S; Weber J; Bickel H
Int J Geriatr Psychiatry; 2017 Jul; 32(7):726-733. PubMed ID: 27271959
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of Florbetapir-PET in Alzheimer's Disease: A Spanish Societal Perspective.
Hornberger J; Michalopoulos S; Dai M; Andrade P; Dilla T; Happich M
J Ment Health Policy Econ; 2015 Jun; 18(2):63-73. PubMed ID: 26231002
[TBL] [Abstract][Full Text] [Related]
14. Adaptation and validation into Portuguese language of the six-item cognitive impairment test (6CIT).
Apóstolo JLA; Paiva DDS; Silva RCGD; Santos EJFD; Schultz TJ
Aging Ment Health; 2018 Sep; 22(9):1184-1189. PubMed ID: 28741373
[TBL] [Abstract][Full Text] [Related]
15. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis.
Ciesielska N; Sokołowski R; Mazur E; Podhorecka M; Polak-Szabela A; Kędziora-Kornatowska K
Psychiatr Pol; 2016 Oct; 50(5):1039-1052. PubMed ID: 27992895
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Quick Mild Cognitive Impairment (Qmci) screen to the Montreal Cognitive Assessment (MoCA) in an Australian geriatrics clinic.
Clarnette R; O'Caoimh R; Antony DN; Svendrovski A; Molloy DW
Int J Geriatr Psychiatry; 2017 Jun; 32(6):643-649. PubMed ID: 27427212
[TBL] [Abstract][Full Text] [Related]
17. Optimal cutoff scores for dementia and mild cognitive impairment of the Montreal Cognitive Assessment among elderly and oldest-old Chinese population.
Tan JP; Li N; Gao J; Wang LN; Zhao YM; Yu BC; Du W; Zhang WJ; Cui LQ; Wang QS; Li JJ; Yang JS; Yu JM; Xia XN; Zhou PY
J Alzheimers Dis; 2015; 43(4):1403-12. PubMed ID: 25147113
[TBL] [Abstract][Full Text] [Related]
18. Validation of the General Practitioner Assessment of Cognition - Chinese version (GPCOG-C) in China.
Li X; Xiao S; Fang Y; Zhu M; Wang T; Seeher K; Brodaty H
Int Psychogeriatr; 2013 Oct; 25(10):1649-57. PubMed ID: 23835084
[TBL] [Abstract][Full Text] [Related]
19. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
